
The authors consider the main endocrinological modifications that happen during the menopausal period, and underline the related metabolic alterations leading the woman to metabolic syndrome and consequently to increase the cardiovascular risk. The components of this syndrome regard the most recent criteria and the respective therapeutic choises are also considered. Moreover, it is encouraged the creation of specifical multi-disciplinar diagnostic and therapeutic iter to prevent the cardiovascular risk in menopause and to improve the life quality in this part of population.

